Company: CMND
Filing Date: 2025-11-26
Form Type: F-1
Source: 0001213900-25-115501
Chunk: 30

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-26
Form: F-1
Chunk 30
---
 LP (29)                    |     |               |   422,288 | -30 |     |                  |   369,502 | -31 |     |               |  52,786 | -32 |     |              |   * |   |
| Hudson                                        
 Bay Master Fund Ltd. (33)                     |     |               |   875,000 | -34 |     |                  |   750,000 | -35 |     |               | 125,000 | -36 |     |              |   * |   |

| * | Less than 1% |

<div align='center'>14</div>

| (1) | The securities are directly held by Lind Global Fund II LP (“Lind”). Jeff Easton is the Managing Member of Lind Global Partners II, LLC, which is the General Partner of Lind Global Fund II LP, and in such capacity has the right to vote and dispose of the securities held by Lind. Mr. Easton disclaims beneficial ownership over the securities listed except to the extent of his pecuniary interest therein. The warrants are subject to a beneficial ownership limitation of 4.99%, which such limitation restricts the selling shareholder from exercising that portion of the warrants that would result in the selling shareholder and its affiliates owning, after exercise, a number of shares of common stock in excess of the beneficial ownership limitation. |
| (2) | Consists of (i) 187,500 common shares issuable upon the exercise of warrants previously issued and (ii) 1,312,500 common shares issuable upon the exercise of the Additional Warrant Shares underlying the January 2024 PIPE Warrants.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| (3) | Consists of 1,312,500 common shares issuable upon the exercise of the Additional Warrant Shares underlying the January 2024 PIPE Warrants.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| (4) | Consists of 187,500 common shares issuable upon the exercise of previously                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
 issued warrants.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| (5) | Richard Abbe is the managing member of Iroquois Capital Investment Group LLC. Mr. Abbe has voting control and investment discretion over securities held by Iroquois Capital Investment Group LLC. As such, Mr. Abbe may be deemed to be a beneficial owner of the securities held by Iroquois Capital Investment Group LLC. The address for Iroquois Capital